[go: up one dir, main page]

ES2183359T3 - Agente desinfectante de pezones por inmersion. - Google Patents

Agente desinfectante de pezones por inmersion.

Info

Publication number
ES2183359T3
ES2183359T3 ES98920795T ES98920795T ES2183359T3 ES 2183359 T3 ES2183359 T3 ES 2183359T3 ES 98920795 T ES98920795 T ES 98920795T ES 98920795 T ES98920795 T ES 98920795T ES 2183359 T3 ES2183359 T3 ES 2183359T3
Authority
ES
Spain
Prior art keywords
immersion
nuts
disinfecting agent
animals
polycharize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98920795T
Other languages
English (en)
Inventor
Olle Larm
Marcus Back
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Application granted granted Critical
Publication of ES2183359T3 publication Critical patent/ES2183359T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Glass Compositions (AREA)
  • Lubricants (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE UNA COMPOSICION, QUE COMPRENDE QUITOSAN, COMBINADO CON UN POLISACARIDO SELECCIONADO ENTRE LA HEPARINA, EL SULFATO DE HEPARAN Y EL SUBSTRATO DE DEXTRAN, COMO COMPONENTE ACTIVO EN DISOLVENTE, PARA LA FABRICACION DE UNA SOLUCION PARA SUMERGIR LAS UBRES DE ANIMALES LACTANTES, PARTICULARMENTE VACAS. LA INVENCION SE REFIERE IGUALMENTE A UN PROCESO PARA EL TRATAMIENTO PROFILACTICO O DE CURACION DE HERIDAS DE ANIMALES LACTANTES, PARTICULARMENTE LAS VACAS, CONTRA LA MASTITIS.
ES98920795T 1997-04-29 1998-04-28 Agente desinfectante de pezones por inmersion. Expired - Lifetime ES2183359T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701616A SE508760C2 (sv) 1997-04-29 1997-04-29 Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur

Publications (1)

Publication Number Publication Date
ES2183359T3 true ES2183359T3 (es) 2003-03-16

Family

ID=20406772

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98920795T Expired - Lifetime ES2183359T3 (es) 1997-04-29 1998-04-28 Agente desinfectante de pezones por inmersion.

Country Status (17)

Country Link
US (1) US6630458B2 (es)
EP (1) EP0917427B1 (es)
JP (1) JP2000515897A (es)
CN (1) CN1225555A (es)
AT (1) ATE223649T1 (es)
AU (1) AU721692B2 (es)
BG (1) BG64027B1 (es)
BR (1) BR9804875A (es)
CA (1) CA2259327A1 (es)
DE (1) DE69807818T2 (es)
DK (1) DK0917427T3 (es)
ES (1) ES2183359T3 (es)
HU (1) HUP0000754A3 (es)
NZ (1) NZ333511A (es)
PL (1) PL330870A1 (es)
SE (1) SE508760C2 (es)
WO (1) WO1998048627A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP659198A0 (en) * 1998-10-19 1998-11-12 Novogen Research Pty Ltd Mastitis treatment
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
JP2004525954A (ja) 2001-04-12 2004-08-26 メディカーブ・アクチエボラーグ 発泡性固体組成物
SE522529C2 (sv) 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
CA2507870A1 (en) * 2001-12-13 2003-07-03 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
DE60229431D1 (de) * 2001-12-14 2008-11-27 Dnp Canada Inc Verwendungen von chitosanoligosacchariden
US20040180015A1 (en) * 2002-01-07 2004-09-16 Kross Robert D. Long-acting disinfecting nitrous acid compositions and related processes
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US8778369B2 (en) * 2005-07-29 2014-07-15 Delaval Holding Ab Barrier film-forming compositions and methods of use
US20070142322A1 (en) * 2005-12-20 2007-06-21 Kaspar Charles W Method of using chitosan to reduce shedding of E. coli from bovines
NZ549249A (en) 2006-08-18 2009-10-30 Univ Massey Methods for reducing the incidence of mastitis by administration of keratin
US8691286B2 (en) * 2009-01-27 2014-04-08 Teleflex Medical Incorporated Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
US9629856B2 (en) 2010-03-03 2017-04-25 Anteis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
US8757092B2 (en) 2011-03-22 2014-06-24 Eco-Composites Llc Animal bedding and associated method for preparing the same
US9737047B2 (en) 2011-03-22 2017-08-22 Ccd Holdings Llc Method for the treatment, control, minimization, and prevention of bovine mastitis
WO2016040873A1 (en) * 2014-09-12 2016-03-17 Ccd Holdings Llc Method for the treatment, control, minimization, and prevention of bovine mastitis
CN104430395B (zh) * 2014-10-30 2016-08-24 青岛青知企业管理咨询有限公司 一种用于防治甘蓝小菜蛾的复配乳油

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
JP3205104B2 (ja) 1992-01-20 2001-09-04 川研ファインケミカル株式会社 化粧料
RU2048473C1 (ru) 1992-12-25 1995-11-20 Гамзазаде Ариф Исмаилович Способ получения интерполимерных комплексов хитозана с декстрансульфатом натрия
SE9300139L (sv) 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel
SE518597C2 (sv) * 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
SE9402531L (sv) * 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
SE507028C2 (sv) 1996-08-06 1998-03-16 Medicarb Ab Ny medicinsk användning

Also Published As

Publication number Publication date
NZ333511A (en) 2000-06-23
EP0917427A1 (en) 1999-05-26
SE9701616D0 (sv) 1997-04-29
EP0917427B1 (en) 2002-09-11
BG103034A (en) 1999-10-29
SE9701616L (sv) 1998-10-30
US20020103159A1 (en) 2002-08-01
CA2259327A1 (en) 1998-11-05
BG64027B1 (bg) 2003-11-28
DK0917427T3 (da) 2002-10-07
CN1225555A (zh) 1999-08-11
SE508760C2 (sv) 1998-11-02
AU721692B2 (en) 2000-07-13
BR9804875A (pt) 2000-01-25
DE69807818D1 (de) 2002-10-17
AU7354898A (en) 1998-11-24
JP2000515897A (ja) 2000-11-28
HUP0000754A2 (en) 2000-07-28
US6630458B2 (en) 2003-10-07
DE69807818T2 (de) 2003-01-16
ATE223649T1 (de) 2002-09-15
WO1998048627A1 (en) 1998-11-05
HUP0000754A3 (en) 2000-11-28
PL330870A1 (en) 1999-06-07

Similar Documents

Publication Publication Date Title
ES2183359T3 (es) Agente desinfectante de pezones por inmersion.
BR9911161A (pt) Processos para o tratamento de um volume particular de tecido de planta ou animal, para produção de pelo menos um agente fotoativado em um volume particular de material, para o tratamento médico de um volume particular de tecido, e, aparelhos para o tratamento de um volume particular de tecido de planta ou animal e, para administração de um tratamento médico fotodinâmico.
BRPI0414331A (pt) método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica
BR0115531A (pt) Tratamento de mucosites
ES2152701T3 (es) Composiciones acuosas desinfectantes y de limpieza.
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
BR0308206A (pt) Composição oral sinergìstica com composto volátil de enxofre para o controle de odor para hálito, e, método para neutralizar sinergisticamente o odor de hálito de composto volátil de enxofre
UY26269A1 (es) Formulación de sal común y moxifloxacina
AR026189A1 (es) Material activo contenido dentro de microesferas de hidrogel
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
ES2159043T3 (es) Derivado carboestirilico para el tratamiento de enfermedades oculares.
BR9814299A (pt) Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
CO5221025A1 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contienen y su uso como agente para la lucha contra organismos daninos
MX2009004692A (es) Composicion para el tratamiento de afecciones de la piel.
WO2007044357A3 (en) Formulations of aica riboside
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
BR0108115A (pt) Uso de uma quantidade eficaz de pelo menos um composto de tipo retinóide como agente antibacteriano e processo de tratamento cosmético para limpar a pele ou corrigir se odor
BR9000026A (pt) Processo para preparar uma formulacao de uma composicao de tiofosfato biocida
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
BR0209846B1 (pt) utilizaÇço de um agente obtido pela irradiaÇço uv artificial de uma soluÇço aquosa para tratamento de esterilizaÇço de instrumentos mÉdicos.
AR003001A1 (es) Composicion farmaceutica estimuladora de la osteogenesis.